PINK:NGENF

NervGen Pharma Corp. Stock Insider Trading

Pink Sheets > Healthcare > Biotechnology

$1.68

+0.0400 (+2.44%)

At Close: Jun 21, 2024

NervGen Pharma Corp. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 NGENF shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About NervGen Pharma Corp.

NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. Its lead product candidate is NVG-291 that is in phase 1 clinical trial for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. The company has a licensing agreement with Case Western Reserve University to resea... NGENF Profile

Golden Star

Ticker	Date	Change	Price
V	Jun 18	0.585%	$273.62
EPD	Jun 18	0.95%	$28.30
USFD	Jun 18	0.565%	$53.14
INTC	Jun 18	1.50%	$30.63
UFPT	Jun 18	3.45%	$253.79
^DJI	Jun 18	0.81%	38,834.86 points
BR	Jun 17	1.59%	$197.65
SARK	Jun 17	1.98%	$30.34
RGA	Jun 17	1.62%	$203.90
MA	Jun 17	1.50%	$448.11

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In